Combretum acutifolium
Combretum acutifolium · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Combretum acutifolium is a botanical species recognized for its significant potential in medicinal applications. Researchers have focused extensively on the diverse therapeutic properties found within its biological makeup. Specifically, scientific investigations have highlighted the plant's potent antibacterial activities against various pathogens. These beneficial effects are most effectively harnessed through the use of specialized plant extracts. Consequently, studying this species offers promising insights into developing new natural antimicrobial agents.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Combretaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Taxonomy
Combretum acutifolium is a fascinating specimen that belongs to the vast kingdom Plantae. Within this botanical realm, it is classified under the class Equisetopsida. The plant further resides in the order Myrtales, showcasing its unique evolutionary lineage. It is a proud member of the Combretaceae family, which helps define its specific biological characteristics. Ultimately, this species is identified by its placement within the genus Combretum.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Combretaceae |
| Genus | Combretum |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Combretum acutifolium is a resilient species with a widespread distribution across the African continent. Its presence is noted in East Tropical Africa, specifically within the regions of Tanzania. The plant also extends into South Tropical Africa, where it can be found in both Angola and Zambia. Furthermore, it inhabits the Northern Provinces of Southern Africa, showcasing its adaptability to various climates. Finally, its range reaches into West-Central Tropical Africa, including the vast landscapes of the DR Congo.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Combretum acutifolium typically manifests as a shrubby plant, though it possesses the versatility to adapt its structure. Depending on its surroundings, it can also exhibit a facultative climbing habit to reach higher light sources.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Combretum acutifolium stands out as one of the most effective species within the Combretaceae family for combating bacterial pathogens. Recent biochemical research has demonstrated that methanol extracts from this plant possess significant antibacterial activity. By utilizing a biochemometric approach, scientists identified that its medicinal potency is closely linked to specific triterpenoid compounds. These biomarkers play a crucial role in the plant's ability to inhibit the growth of various harmful bacteria. Such findings highlight the potential of this species to serve as a valuable source for developing new antibiotic treatments.
Compounds
Conditions
Combretum acutifolium demonstrates significant antibacterial potential through its methanol extracts. Specifically, the plant serves as an effective agent against the Gram-positive pathogen Bacillus cereus ATCC 11778. It also exhibits targeted activity against the Gram-negative bacterium Salmonella typhimurium ATCC 14028. These therapeutic effects are attributed to the presence of triterpenoid compounds identified within the species. Consequently, Combretum acutifolium acts as a potent source of antimicrobial compounds for treating these specific bacterial infections.
Preparations
Combretum acutifolium is prepared as methanol extracts to investigate its medicinal potential. These specific extracts are evaluated for their broad-spectrum antibacterial properties against various pathogenic bacteria. Research shows that the extracts of this species demonstrate significant activity, particularly with an average minimum inhibitory concentration of 0.70 mg/mL. The study utilizes a biochemometric approach to correlate the efficacy of these extracts with their underlying phytochemical composition. Ultimately, the analysis identifies triterpenoids within the prepared extracts as the compounds responsible for their antibacterial effects.